Bailard buys $2,830,393 stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Bailard scooped up 34,942 additional shares in Colgate-Palmolive Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 37,794 shares of Colgate-Palmolive Company which is valued at $2,830,393.Colgate-Palmolive Company makes up approximately 0.33% of Bailard’s portfolio.

Other Hedge Funds, Including , Finemark National Bank Trust reduced its stake in CL by selling 4,885 shares or 18.39% in the most recent quarter. The Hedge Fund company now holds 21,679 shares of CL which is valued at $1,623,540. Colgate-Palmolive Company makes up approx 0.17% of Finemark National Bank Trust’s portfolio.Congress Asset Management Co reduced its stake in CL by selling 19,440 shares or 2.34% in the most recent quarter. The Hedge Fund company now holds 813,013 shares of CL which is valued at $60,634,510. Colgate-Palmolive Company makes up approx 1.34% of Congress Asset Management Co’s portfolio.Financial Architects Inc boosted its stake in CL in the latest quarter, The investment management firm added 1,227 additional shares and now holds a total of 4,403 shares of Colgate-Palmolive Company which is valued at $322,652. Colgate-Palmolive Company makes up approx 0.09% of Financial Architects Inc’s portfolio.Barrett Asset Management reduced its stake in CL by selling 5,164 shares or 27.67% in the most recent quarter. The Hedge Fund company now holds 13,500 shares of CL which is valued at $1,000,620. Colgate-Palmolive Company makes up approx 0.08% of Barrett Asset Management’s portfolio.Wendell David Associates Inc reduced its stake in CL by selling 6,250 shares or 2.77% in the most recent quarter. The Hedge Fund company now holds 219,511 shares of CL which is valued at $16,270,155. Colgate-Palmolive Company makes up approx 3.11% of Wendell David Associates Inc’s portfolio.

Colgate-Palmolive Company closed down -0.26 points or -0.35% at $74.71 with 23,75,818 shares getting traded on Monday. Post opening the session at $75, the shares hit an intraday low of $74.635 and an intraday high of $75.24 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Colgate-Palmolive Company reported $0.70 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.69. The company had revenue of $3845.00 million for the quarter, compared to analysts expectations of $3859.81 million. The company’s revenue was down -5.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.70 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Downgraded by Exane BNP Paribas to ” Neutral” on Jul 29, 2016.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.